Replication of genetic loci implicated in diabetic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 3, 2014, Pages 1666-1671

  McAuley, Annie K ^a   Wang, Jie Jin ^a,b   Dirani, Mohamed ^a   Connell, Paul P ^a,c   Lamoureux, Ecosse ^a   Hewitt, Alex W ^a,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Clinical management; Diabetic retinopathy; Single nucleotide polymorphism

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

CLINICAL MANAGEMENT; DIABETIC RETINOPATHY; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CROSS-SECTIONAL STUDIES; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RETROSPECTIVE STUDIES; VICTORIA;

EID: 84897835575     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13559     Document Type: Article

References (34)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 87:4-14.
2. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Longterm follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359:1565-1576.
3. Simmons RK, Coleman RL, Price HC, et al. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in estimating cardiovascular disease in the EPIC-Norfolk Cohort. Diabetes Care. 2009;32:708-713.
4. Rema M, Saravanan G, Deepa R, Mohan V. Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients. Diabet Med. 2002;19:910-916.
5. Hietala K, Forsblom C, Summanen P, Groop PH. Heritability of proliferative diabetic retinopathy. Diabetes. 2008;57:2176-2180.
6. Arar NH, Freedman BI, Adler SG, et al. Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci. 2008;49:3839-3845.
7. Heng LZ, Comyn O, Peto T, et al. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med. 2013;30:640-650.
8. Abhary S, Hewitt AW, Burdon KP, Craig JE. A systematic metaanalysis of genetic association studies for diabetic retinopathy. Diabetes. 2009;58:2137-2147.
9. Grassi MA, Tikhomirov A, Ramalingam S, Below JE, Cox NJ, Nicolae DL. Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet. 2011;20:2472-2481.
10. Huang YC, Lin JM, Lin HJ, et al. Genome-wide association study of diabetic retinopathy in a Taiwanese population. Ophthalmology. 2011;118:642-648.
11. Grassi MA, Tikhomirov A, Ramalingam S, et al. Replication analysis for severe diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012;53:2377-2381.
12. Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2011;35:556-564.
13. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44: 156-163.
14. Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care. 2001;24:1275-1279.
15. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-1589.
16. Lamoureux EL, Fenwick E, Xie J, et al. Methodology and early findings of the Diabetes Management Project: a cohort study investigating the barriers to optimal diabetes care in diabetic patients with and without diabetic retinopathy. Clin Experiment Ophthalmol. 2012;40:73-82.
17. Klein R, Klein BE, Magli YL, et al. An alternative method of grading diabetic retinopathy. Ophthalmology. 1986;93:1183-1187.
18. Group ETDRSR. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:786-806.
19. ETDRS Coordinating Center UoMDoEaPM. Early Treatment Diabetic Retinopathy Study (ETDRS) Manual of Operation. Springfield, VA: National Technical Information Service (Accession Number PB85223006); 1980.
20. Purcell SNB, Todd-Brown K, Thomas L, et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet. 2007;81:559-575.
21. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19:149-150.
22. Stitt AW, McKenna D, Simpson DA, et al. The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy. Am J Pathol. 1998;152:1359-1365.
23. McDonald L, Lee GR, Degooyer TE, et al. Effects of an endothelin receptor antagonist on a model of hypertensive retinopathy. Ophthalmic Res. 2010;43:99-107.
24. Gebarowska D, Stitt AW, Gardiner TA, Harriott P, Greer B, Nelson J. Synthetic peptides interacting with the 67-kd laminin receptor can reduce retinal ischemia and inhibit hypoxiainduced retinal neovascularization. Am J Pathol. 2002;160: 307-313.
25. Van den Broeke A, Van Poucke M, Marcos-Carcavilla A, et al. Characterization of the ovine ribosomal protein SA gene and its pseudogenes. BMC Genomics. 2013;11:179.
26. Strunnikova NV, Maminishkis A, Barb JJ, et al. Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum Mol Genet. 2010;19:2468-2486.
27. Sanz-Moreno V, Gadea G, Ahn J, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell. 2008;135:510-523.
28. Wolf K, Mazo I, Leung H, et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol. 2003;160:267-277.
29. Aiello LPAR, Arrigg PG, Keyt BA, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994; 331:1480-1487.
30. Duh EJ, Yang HS, Haller JA, et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol. 2004;137:668-674.
31. Lewis CM, Knight J. Introduction to genetic association studies. Cold Spring Harb Protoc. 2012;2012:297-306.
32. Hart AB, de Wit H, Palmer AA. Candidate gene studies of a promising intermediate phenotype: failure to replicate. Neuropsychopharmacology. 2013;38:802-816.
33. Neale BM, Sham PC. The future of association studies: genebased analysis and replication. Am J Hum Genet. 2004;75: 353-362.
34. Wray NR, Yang J, Hayes BJ, Price AL, Goddard ME, Visscher PM. Pitfalls of predicting complex traits from SNPs. Nat Rev Genet. 2013;14:507-515.